Pharmaceutical News

RSS

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.

25 Sep 2024

Higher doses of buprenorphine linked to lower emergency visits in opioid use disorder

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of inpatient services related to behavioral health (such as for mental health and substance use disorders) than adults receiving the recommended dose, according to an analysis funded by the National Institutes of Health (NIH).

25 Sep 2024

Chemical genetics uncovers promising anti-COVID compounds

This new article publication from Acta Pharmaceutica Sinica B, discusses the identification of novel small-molecule inhibitors of SARS-CoV-2 by chemical genetics.

25 Sep 2024

Research uncovers mechanism of psychedelic-induced anxiety reduction

A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such drugs reduce anxiety, according to a new study.

24 Sep 2024

Brain connectivity changes after psilocybin treatment in body dysmorphic disorder patients

Body dysmorphic disorder (BDD) is a debilitating mental illness characterized by an obsessive preoccupation with perceived flaws in one's physical appearance.

24 Sep 2024

Lack of awareness contributes to under-reporting of adverse drug reactions

Around 75% of Australians have experienced a bad reaction to a medication, but fewer than half have reported it to a doctor or the Therapeutic Goods Administration (TGA), a new survey has found.

24 Sep 2024

Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials

Study explores the potential to repurpose neuroactive drugs, originally approved for neurological disorders, for the treatment of glioblastoma. Vortioxetine, an antidepressant, showed promising anti-glioblastoma activity, significantly reducing tumor size in preclinical trials.

24 Sep 2024

Liraglutide activates key brain circuits to trigger weight loss in obesity

Researchers uncover how liraglutide targets specific brain regions to suppress appetite and promote significant weight loss through GLP-1 receptor activation.

23 Sep 2024

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic kidney disease compared to those who received GLP-1 diabetes medications. The paper was published in Annals of Surgery.

20 Sep 2024

Promising antidepressant offers hope for glioblastoma treatment

Glioblastoma is a particularly aggressive brain tumor that at present is incurable. Cancer doctors can extend patients' life expectancy through operations, radiation, chemotherapy or surgical interventions. Nevertheless, half of patients die within twelve months of diagnosis.

20 Sep 2024

FUJIFILM Irvine Scientific develops Oceo Rover: The first automated single-use hydration system for media and buffers

FUJIFILM Irvine Scientific, Inc., a world leader in the development and manufacture of serum-free and chemically defined cell culture media for bioproduction and cell therapy manufacturing, today announced the development of Oceo Rover, a first-of-its-kind* single-use technology system, that enables manufacturers of biopharmaceuticals to improve bioprocessing workflows by automating and simplifying the hydration of media, feeds, and buffers.

From FUJIFILM Irvine Scientific 20 Sep 2024

Triptans prove to be more effective for acute migraines than newer drugs

Some triptans are a more effective treatment for acute migraines than newer, more expensive drugs, finds an analysis of the latest evidence published by The BMJ today.

18 Sep 2024

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study published in the September 18, 2024, online issue of Neurology, the medical journal of the American Academy of Neurology.

18 Sep 2024

Antibiotic resistance threatens millions of lives worldwide

More than 39 million people around the world could die from antibiotic-resistant infections over the next 25 years, according to a study published in The Lancet.

18 Sep 2024

Low-dose ketamine eases fentanyl withdrawal symptoms

Drug overdose is the leading cause of injury deaths in young adults in the United States, with fentanyl causing over 70,000 deaths annually.

17 Sep 2024

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Researchers compare the weight loss efficacy of injectable liraglutide and semaglutide.

17 Sep 2024

Cognitive distortions and deliberate ignorance lead to COVID-19 vaccine refusal, study says

Researchers find that deliberate ignorance and cognitive distortions drive COVID-19 vaccine refusal, emphasizing the need for tailored communication strategies.

17 Sep 2024

Study highlights limited evidence for antidepressants in treating pain in older adults

University of Sydney research has found people over 65 are being prescribed antidepressants as pain treatment based on international guidelines that use limited evidence.

16 Sep 2024

Single dose of MVA-BN vaccine offers 58% protection against mpox

Researchers confirm the effectiveness of the modified vaccinia Ankara-Bavarian Nordic vaccine against mpox.

16 Sep 2024

Cardiovascular risks of COVID-19 antivirals

Study reviews cardiovascular side effects linked to antiviral therapies for COVID-19, highlighting the need for careful consideration when prescribing these drugs to high-risk patients.

16 Sep 2024

Previous
1
...
13
14
15
16
17
18
19
...
1443
Next

Pharmaceutical News

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Higher doses of buprenorphine linked to lower emergency visits in opioid use disorder

Chemical genetics uncovers promising anti-COVID compounds

Research uncovers mechanism of psychedelic-induced anxiety reduction

Brain connectivity changes after psilocybin treatment in body dysmorphic disorder patients

Lack of awareness contributes to under-reporting of adverse drug reactions

Neuroactive drugs show promising anti-glioblastoma effects in preclinical trials

Liraglutide activates key brain circuits to trigger weight loss in obesity

Bariatric surgery outperforms GLP-1 medications in protecting kidney function

Promising antidepressant offers hope for glioblastoma treatment

FUJIFILM Irvine Scientific develops Oceo Rover: The first automated single-use hydration system for media and buffers

Triptans prove to be more effective for acute migraines than newer drugs

Study links diabetes drugs to lower risk of dementia and Parkinson's disease

Antibiotic resistance threatens millions of lives worldwide

Low-dose ketamine eases fentanyl withdrawal symptoms

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes

Cognitive distortions and deliberate ignorance lead to COVID-19 vaccine refusal, study says

Study highlights limited evidence for antidepressants in treating pain in older adults

Single dose of MVA-BN vaccine offers 58% protection against mpox

Cardiovascular risks of COVID-19 antivirals

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Latest News